FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

427292001: Insulin aspart protamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661317015 Insulin aspart protamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673417010 Insulin aspart protamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488093016 Insulin aspart protamine crystallised en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488094010 Insulin aspart protamine crystallized en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
25201000188116 insuline aspart recombinante fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817921000172118 insuline aspart fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin aspart protamine (substance) Is a Insulin aspart false Inferred relationship Some
Insulin aspart protamine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) true Inferred relationship Some
Insulin aspart protamine (substance) Is a Short-acting insulin false Inferred relationship Some
Insulin aspart protamine (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Insulin aspart false Inferred relationship Some
Insulin aspart protamine (substance) Is a Human insulin true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart protamine (substance) Inferred relationship Some 1
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine (substance) Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine (substance) Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine (substance) Inferred relationship Some
Insulin biphasic aspart 50/50 100units/mL injection solution 3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine (substance) Inferred relationship Some
Insulin biphasic aspart 50/50 100units/mL injection solution 3mL prefilled cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart protamine (substance) Inferred relationship Some
Insulin aspart and insulin aspart protamine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart protamine (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start